IT1396649B1 - PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM. - Google Patents

PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM.

Info

Publication number
IT1396649B1
IT1396649B1 ITMI2009A002151A ITMI20092151A IT1396649B1 IT 1396649 B1 IT1396649 B1 IT 1396649B1 IT MI2009A002151 A ITMI2009A002151 A IT MI2009A002151A IT MI20092151 A ITMI20092151 A IT MI20092151A IT 1396649 B1 IT1396649 B1 IT 1396649B1
Authority
IT
Italy
Prior art keywords
floroglucinol
drugs
prevention
treatment
pharmaceutical preparations
Prior art date
Application number
ITMI2009A002151A
Other languages
Italian (it)
Inventor
Serraima Cristina Carreno
Original Assignee
Diverdrugs Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diverdrugs Sl filed Critical Diverdrugs Sl
Priority to ITMI2009A002151A priority Critical patent/IT1396649B1/en
Priority to PCT/IB2010/003109 priority patent/WO2011067663A1/en
Publication of ITMI20092151A1 publication Critical patent/ITMI20092151A1/en
Application granted granted Critical
Publication of IT1396649B1 publication Critical patent/IT1396649B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI2009A002151A 2009-12-04 2009-12-04 PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM. IT1396649B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITMI2009A002151A IT1396649B1 (en) 2009-12-04 2009-12-04 PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM.
PCT/IB2010/003109 WO2011067663A1 (en) 2009-12-04 2010-12-03 Pharmaceutical preparations comprising phloroglucinol and/or derivatives thereof and some non-steroidal anti-inflammatory drugs and their use in the treatment and/or prevention of pain syndromes of the feminine genital system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A002151A IT1396649B1 (en) 2009-12-04 2009-12-04 PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM.

Publications (2)

Publication Number Publication Date
ITMI20092151A1 ITMI20092151A1 (en) 2011-06-05
IT1396649B1 true IT1396649B1 (en) 2012-12-14

Family

ID=42102019

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A002151A IT1396649B1 (en) 2009-12-04 2009-12-04 PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM.

Country Status (2)

Country Link
IT (1) IT1396649B1 (en)
WO (1) WO2011067663A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2984165B1 (en) * 2011-12-16 2014-06-27 Pharmeuro TREATMENT OF MIGRAINE CRISES, INCLUDING FACE VASCULAR ALGIES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735025B1 (en) * 1995-06-12 1997-08-22 Fabre Pierre Sante THERAPEUTIC COMPOSITION CONTAINING A COMBINATION OF IBUPROFEN AND PHLOROGLUCINOL AND ITS USE AS ANTISPASMODE
FR2912654B1 (en) * 2007-02-19 2009-12-25 Rech En Toxicologie Et Pharmac DRUG ASSOCIATION COMPRISING PHLOROGLUCINOL AND PARACETAMOL

Also Published As

Publication number Publication date
ITMI20092151A1 (en) 2011-06-05
WO2011067663A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
CY1119140T1 (en) COMPOSITION COMPOSITIONS AND METHODS OF CONSTRUCTION AND USE
DK1957110T3 (en) PROCEDURE FOR THE PREPARATION OF CHEWABLE DOSAGE FORMS FOR MEDICINE ADMINISTRATION AND PRODUCTS THEREOF
CL2013001654A1 (en) Compounds derived from 6-amino-2-phenylamino-1h-benzimidazol-5-carboxamide; pharmaceutical composition; and its use in the treatment and / or prevention of inflammatory diseases and / or associated conditions, in particular pain.
IL206296A (en) Aminopyrazole derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for prevention or treatment of diseases
BRPI0816255A2 (en) Pharmaceutical product, use of the product, method for the prophylaxis or treatment of diseases, and pharmaceutically acceptable composition.
IL271352B (en) Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases
SMT201400076B (en) Pharmaceutical formulations against the improper use of medicines
BRPI0812738A2 (en) COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, AND METHOD FOR THE TREATMENT OF A VIRAL INFECTION IN A HUMAN
CL2007001724A1 (en) USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
ATE505203T1 (en) PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN
IL233693A (en) Transmucosal administration system for a pharmaceutical drug and such a system for use in the treatment of a mitochondrial disease
GT201400059A (en) DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
FR2937972B1 (en) OXOAZETIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS
CL2013001564A1 (en) Method to treat overweight or obesity that includes administering naltrexone and bupropion; method to increase the bioavailability of naltrexone and bupropion in a combination therapy; use of naltrexone and bupropion to treat overweight or obesity and increase the bioavailability of these drugs; pharmaceutical composition
TN2010000135A1 (en) Galenical formulations of organic compounds
MA50189A (en) CYCLIC OLIGOMER AND ABIRATERONE PHARMACEUTICAL FORMULATIONS AND PROCESSES FOR FORMING AND ADMINISTERING THE SAME
IL194880A (en) Aminothiazole derivatives, their use in the treatment of diseases and pharmaceutical compositions comprising them
BRPI0818267A2 (en) New 1,3-dihydro-5-isobenzofuranocarbonitrile derivatives and their pharmaceutical composition for the treatment of premature ejaculation
ITPD20050168A1 (en) FORMULATIONS OF LIPOIC ACID AND HYALURONIC ACID AND OR ITS DERIVATIVES AND THEIR USE IN THE PHARMACEUTICAL AND COSMETIC FIELD
CL2016000170A1 (en) Combination of oxycodone and naloxone for use in the treatment of pain in patients suffering from pain and a disease that results in intestinal dysbiosis and / or increased risk of intestinal bacterial translocation.
IT1396915B1 (en) DIETYL- [6- (4-HYDROXICARBAMYL-PHENYL-CARBAMYLOSSIMETHYL) -NAFTALEN-2-IL-METHYL] -AMMONIUM CHLORIDE AND OTHER DERIVATIVES OF N-HYDROXY-BENZAMID FOR THE USE IN THE TREATMENT OF HIV INFECTIONS.
IT1396649B1 (en) PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM.
ITMI20021866A1 (en) PHARMACEUTICAL PREPARATION IN COLLOIDAL FORM USEFUL IN THE TREATMENT OF SKIN DISEASES.